CLLS

CLLS

USD

Cellectis S.A. American Depositary Shares

$3.580-0.010 (-0.279%)

即時價格

Healthcare
生物科技
法國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$3.590

最高

$3.710

最低

$3.480

交易量

0.00M

公司基本面

市值

368.0M

行業

生物科技

國家

France

交易統計

平均交易量

0.13M

交易所

NGM

貨幣

USD

52週範圍

最低 $1.1當前 $3.580最高 $5.48

相關新聞

GlobeNewswire

Cellectis to Present a Development Update for eti-cel at ASH 2025

Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes in r/r NHLPreclinical data demonstrated that combining eti-cel with

查看更多
Cellectis to Present a Development Update for eti-cel at ASH 2025
GlobeNewswire

Cellectis to Report Third Quarter Financial Results on November 7, 2025

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies,

查看更多
Cellectis to Report Third Quarter Financial Results on November 7, 2025